Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Elevance Advances Metathesis Route
by Alexander H. Tullo
January 25, 2016
| A version of this story appeared in
Volume 94, Issue 4
Elevance Renewable Sciences, an Illinois-based start-up that uses metathesis to convert natural oils into specialty chemicals, says it has scaled up what it calls a “second generation” of metathesis technology. Dubbed ethenolysis, the technology reacts oils with ethylene using molybdenum and tungsten catalysts based on those developed by Chemistry Nobel Laureate Richard Schrock and made by the Swiss firm XiMo. The trial was partially funded by Versalis, which is developing a plant in Italy to react butene and natural oils, and the United Soybean Board.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X